Surgical procedures are frequently introduced into general practiceon the basis of uncontrolled studies that are less rigorousthan those required for the approval of medical interventions.1The standard for the evaluation of surgical therapy is lowerbecause of the complexity of designing and conducting scientificallyvalid and ethically acceptable clinical trials of surgical procedures.2As a result, many surgical trials fail to control for investigatorbias or placebo effects.3,4
The list of inadequately studied invasive or surgical proceduresthat became part of standard medical practice only to be abandonedafter closer scrutiny includes bloodletting, routine tonsillectomy,routine circumcision, repeated . . . [Full Text of this Article]
Ethics of Placebo-Controlled Trials
A Placebo-Controlled Trial of Fetal Nigral Transplantation in Parkinson's Disease
Placebo Effects in the Treatment of Parkinson's Disease
The Trial Design
Risks and Benefits of Participating in the Placebo Group
Oken, B. S.
(2008). Placebo effects: clinical aspects and neurobiology. Brain
0: awn116v1-awn116
[Abstract][Full Text]
Sutherland, E. R.
(2007). Sham Procedure versus Usual Care as the Control in Clinical Trials of Devices: Which is Better?. Proc Am Thorac Soc
4: 574-576
[Abstract][Full Text]
Cornblath, D. R., Vinik, A., Feldman, E., Freeman, R., Boulton, A. J.M.
(2007). Surgical Decompression for Diabetic Sensorimotor Polyneuropathy. Diabetes Care
30: 421-422
[Full Text]
Rascol, O.
(2005). Assessing the risk of a necessary harm: Placebo surgery in Parkinson disease. Neurology
65: 982-983
[Full Text]
Frank, S., Kieburtz, K., Holloway, R., Kim, S. Y.H.
(2005). What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports. Neurology
65: 1101-1103
[Abstract][Full Text]
Olanow, C. W.
(2005). Double-Blind, Placebo-Controlled Trials for Surgical Interventions in Parkinson Disease. Arch Neurol
62: 1343-1344
[Full Text]
Kim, S. Y. H., Frank, S., Holloway, R., Zimmerman, C., Wilson, R., Kieburtz, K.
(2005). Science and Ethics of Sham Surgery: A Survey of Parkinson Disease Clinical Researchers. Arch Neurol
62: 1357-1360
[Abstract][Full Text]
Albin, R L
(2005). Sham surgery controls are mitigated trolleys. J. Med. Ethics
31: 149-152
[Abstract][Full Text]
Miller, F. G, Kaptchuk, T. J
(2004). Sham procedures and the ethics of clinical trials. JRSM
97: 576-578
[Full Text]
Stirrat, G M
(2004). Ethics and evidence based surgery. J. Med. Ethics
30: 160-165
[Abstract][Full Text]
Levine, C., Faden, R., Grady, C., Hammerschmidt, D., Eckenwiler, L., Sugarman, J., on behalf of the Consortium to Examine Clinical Re,
(2004). "Special Scrutiny": A Targeted Form of Research Protocol Review. ANN INTERN MED
140: 220-223
[Abstract][Full Text]
Heckerling, P. S.
(2003). Ethical Aspects in Trials of Implantable Medical Devices. JAMA
290: 1579-1579
[Full Text]
Olanow, C. W.
(2003). Present and future directions in the management of motor complications in patients with advanced PD. Neurology
61: S24-33
[Full Text]
Siderowf, A., Stern, M.
(2003). Update on Parkinson Disease. ANN INTERN MED
138: 651-658
[Abstract][Full Text]
de la Fuentefernandez, R., Stoessl, A. J.
(2002). The Biochemical Bases for Reward: Implications for the Placebo Effect. Eval Health Prof
25: 387-398
[Abstract]
London, A. J., Kadane, J. B.
(2002). Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res
11: 413-427
[Abstract]
Albin, R L
(2002). Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls. J. Med. Ethics
28: 322-325
[Abstract][Full Text]
Horng, S., Miller, F. G.
(2002). Is Placebo Surgery Unethical?. NEJM
347: 137-139
[Full Text]
Clark, P. A.
(2002). Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?. J Law Med Ethics
30: 58-68
Levine, S. B., Stagno, S. J.
(2001). Informed Consent for Case Reports: The Ethical Dilemma of Right to Privacy Versus Pedagogical Freedom. J. Psychother. Pract. Res.
10: 193-201
[Abstract][Full Text]
Olanow, C. W., Watts, R. L., Koller, W. C.
(2001). An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment. Neurology
56: S1-S88
[Full Text]
Dekkers, W., Boer, G.
(2001). Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?. J. Med. Ethics
27: 151-156
[Abstract][Full Text]
Halpern, S. D., Karlawish, J. H. T., Preston, R. A., Materson, B. J., Reda, D. J.
(2000). Placebo-Controlled Trials Are Unethical in Clinical Hypertension Research. Arch Intern Med
160: 3167-3169
[Full Text]
Studer, L., Csete, M., Lee, S.-H., Kabbani, N., Walikonis, J., Wold, B., McKay, R.
(2000). Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen. J. Neurosci.
20: 7377-7383
[Abstract][Full Text]
Lang, A. E.
(2000). Surgery for Parkinson Disease: A Critical Evaluation of the State of the Art. Arch Neurol
57: 1118-1125
[Full Text]
Weiner, W. J., Burris, J. F., Freed, C. R., Breeze, R. E., Fahn, S., Slattery, J., Horisberger, J.-D., Freeman, T. B., Vawter, D. E., Olanow, C. W., Macklin, R.
(2000). Placebo Surgery in Trials of Therapy for Parkinson's Disease. NEJM
342: 353-355
[Full Text]